These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 32308997)

  • 1. Clinicopathological and Prognostic Characteristics of Malaysian Triple Negative Breast Cancer Patients Undergoing TAC Chemotherapy Regimen.
    Abdul Aziz AA; Md Salleh MS; Ankathil R
    Int J Breast Cancer; 2020; 2020():8424365. PubMed ID: 32308997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant Chemotherapy.
    Bonsang-Kitzis H; Chaltier L; Belin L; Savignoni A; Rouzier R; Sablin MP; Lerebours F; Bidard FC; Cottu P; Sastre-Garau X; Laé M; Pierga JY; Reyal F
    PLoS One; 2015; 10(12):e0144359. PubMed ID: 26684197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic analysis of triple-negative breast cancer patients treated with adjuvant chemotherapy of fluorouracil, epirubicin and cyclophosphamide.
    Sun W; Li C; Liu M; Liu W; Yang C; Cai LI
    Oncol Lett; 2016 Mar; 11(3):2320-2326. PubMed ID: 26998170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Axillary lymph node micrometastases decrease triple-negative early breast cancer survival.
    Houvenaeghel G; Sabatier R; Reyal F; Classe JM; Giard S; Charitansky H; Rouzier R; Faure C; Garbay JR; Daraï E; Hudry D; Gimbergues P; Villet R; Lambaudie E
    Br J Cancer; 2016 Oct; 115(9):1024-1031. PubMed ID: 27685443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognosis in different subtypes of metaplastic breast cancer: a population-based analysis.
    He X; Ji J; Dong R; Liu H; Dai X; Wang C; Esteva FJ; Yeung SJ
    Breast Cancer Res Treat; 2019 Jan; 173(2):329-341. PubMed ID: 30341462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The taxane-based chemotherapy triplet is superior to the doublet in one to nine node-positive but not node-negative triple-negative breast cancer: results from a retrospective analysis.
    Guo S; Shi Y; Lu S; He Y; Jin G; Zhang S; Li X
    J Cancer; 2020; 11(22):6653-6662. PubMed ID: 33046986
    [No Abstract]   [Full Text] [Related]  

  • 7. Impact of type 2 diabetes mellitus on the prognosis of early stage triple-negative breast cancer in People's Republic of China.
    Ma FJ; Liu ZB; Qu L; Hao S; Liu GY; Wu J; Shao ZM
    Onco Targets Ther; 2014; 7():2147-54. PubMed ID: 25473296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of Clinical Features and Outcome of 356 Triple-Negative Breast Cancer Patients in China.
    Zhang L; Hao C; Dong G; Tong Z
    Breast Care (Basel); 2012 Feb; 7(1):13-17. PubMed ID: 22553467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metaplastic Carcinoma of the Breast Is More Aggressive Than Triple-negative Breast Cancer: A Study From a Single Institution and Review of Literature.
    El Zein D; Hughes M; Kumar S; Peng X; Oyasiji T; Jabbour H; Khoury T
    Clin Breast Cancer; 2017 Aug; 17(5):382-391. PubMed ID: 28529029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical features and prognosis of patients with first-episode liver metastasis of different molecular subtypes of breast cancer].
    Wu SY; Tan Y; Guan YS
    Zhonghua Gan Zang Bing Za Zhi; 2016 Jun; 24(6):422-8. PubMed ID: 27465945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Safety of breast-conserving treatment for triple-negative breast cancer].
    Wang L; Ouyang T; Wang T; Xie Y; Fan Z; Fan T; Li J
    Zhonghua Wai Ke Za Zhi; 2015 Dec; 53(12):947-52. PubMed ID: 26850668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of transforming growth factor-β1 in triple negative breast cancer patients.
    Zhang M; Wu J; Mao K; Deng H; Yang Y; Zhou E; Liu J
    Int J Surg; 2017 Sep; 45():72-76. PubMed ID: 28754615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expressions of NEDD9 and E-cadherin correlate with metastasis and poor prognosis in triple-negative breast cancer patients.
    Li P; Sun T; Yuan Q; Pan G; Zhang J; Sun D
    Onco Targets Ther; 2016; 9():5751-5759. PubMed ID: 27703373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Clinicopathological Features and Survival Outcomes of Different Histological Subtypes in Triple-negative Breast Cancer.
    Liao HY; Zhang WW; Sun JY; Li FY; He ZY; Wu SG
    J Cancer; 2018; 9(2):296-303. PubMed ID: 29344276
    [No Abstract]   [Full Text] [Related]  

  • 15. The Outcome of Patients with Triple Negative Breast Cancer: The Turkish Oncology Group Experience.
    Eralp Y; Kılıç L; Alço G; Başaran G; Doğan M; Dinçol D; Demirci S; İçli F; Onur H; Saip P; Haydaroğlu A
    J Breast Health; 2014 Oct; 10(4):209-215. PubMed ID: 28331673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic Association of CYP1B1 4326 C>G Polymorphism with Disease-Free Survival in TNBC Patients Undergoing TAC Chemotherapy Regimen.
    Abdul Aziz AA; Md Salleh MS; Yahya MM; Zakaria AD; Ankathil R
    Asian Pac J Cancer Prev; 2021 Apr; 22(4):1319-1324. PubMed ID: 33906328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of BRCA1-IRIS in the development and progression of triple negative breast cancers in Egypt: possible link to disease early lesion.
    Bogan D; Meile L; El Bastawisy A; Yousef HF; Zekri AN; Bahnassy AA; ElShamy WM
    BMC Cancer; 2017 May; 17(1):329. PubMed ID: 28499366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics and prognostic analysis of triple-negative breast cancer patients.
    Yuan N; Meng M; Liu C; Feng L; Hou L; Ning Q; Xin G; Pei L; Gu S; Li X; Zhao X
    Mol Clin Oncol; 2014 Mar; 2(2):245-251. PubMed ID: 24649341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of CD44 and CD24 phenotype with lymph node metastasis and survival in triple-negative breast cancer.
    Zou W; Yang Y; Zheng R; Wang Z; Zeng H; Chen Z; Yang F; Wang J
    Int J Clin Exp Pathol; 2020; 13(5):1008-1016. PubMed ID: 32509072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of proline, glutamic acid, leucine rich protein 1 (PELP1) in triple-negative breast cancer: a retrospective study on 129 cases.
    Zhang Y; Dai J; McNamara KM; Bai B; Shi M; Chan MS; Liu M; Sasano H; Wang X; Li X; Liu L; Ma Y; Cao S; Xing Y; Zhao B; Song Y; Wang L
    BMC Cancer; 2015 Oct; 15():699. PubMed ID: 26472563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.